Intensive insulin therapy to prevent the progression of chronic vascular complications in type 2 diabetes mellitus
Kishikawa, H.; Araki, E.; Wake, N.; Shichiri, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 60 Suppl. 9: 140-145
2002
ISSN/ISBN: 0047-1852 PMID: 12386985 Document Number: 547851
Document emailed within 1 workday
Related Documents
Kobayashi, K.; Nakashima, N.; Inoguchi, T.; Takayanagi, R. 2012: Disease management for diabetes mellitus to prevent the onset and progression of complications Rinsho Byori. Japanese Journal of Clinical Pathology 60(11): 1101-1106Mozdzan, M.ł; Mozdzan, M.; Loba, J.; Markuszewski, L.; Ruxer, J. 2006: Effect of short-term intensive insulin therapy on daily insulin requirement in poorly controlled type 2 diabetes patients Wiadomosci Lekarskie 59(3-4): 203-207
Dahiya, K.; Aggarwal, K.; Seth, S.; Singh, V.; Sharma, T.K. 2010: Type 2 Diabetes Mellitus Without Vascular Complications and Ischemia Modified Albumin Clinical Laboratory 56(5-6): 187-190
DeWitt, D.E.; Hirsch, I.B. 2003: Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review JAMA 289(17): 2254-2264
Ametov, A.S.; Kochergina, I.I.; Ulanova, K.A. 2010: Effect of insulin therapy on insulin resistance and risk for ischemic heart disease and death from cardiovascular pathology in patients with diabetes mellitus, type 2 Terapevticheskii Arkhiv 82(3): 42-46
Jungmann, E.; Helling, T.; Jungmann, G.; Mertens, C.; Snelting, U. 2001: Intensified conventional insulin therapy in patients with type 2 diabetes mellitus. Positive long-term effects of insulin lispro on metabolic control and microalbuminuria Fortschritte der Medizin. Originalien 118(4): 141-146
Sahay, B.K. 2011: Insulin therapy at onset of type 2 diabetes mellitus--a new concept Journal of the Association of Physicians of India 59 Suppl: 13-15
Rausch, R. 2014: Diabetes mellitus type 1 and 2. Flexible therapy with insulin degludec Medizinische Monatsschrift für Pharmazeuten 37(7): 273-274
Dakhli, S.; Lamine, S.; Lamine, F.; Trabelsi, N.; Aouididi, F.; Zouaoui, C.; Mami, F.Ben.; Achour, A. 2007: Blood pressure and type 2 diabetes mellitus: impact of the insulin therapy La Tunisie Medicale 85(11): 945-950
Sánchez Sánchez, O.; Sabán Ruiz, Jé. 2008: Lights and shades in the application of new guidelines for the management of type 2 diabetes mellitus. Practical advice about combined therapy and insulin therapy Medicina Clinica 130(5): 188-196
DZugkoev, S.G.; Zangieva, O.D.; Dzugkoeva, F.S. 2013: Influence of combined treatment on biochemical and functional characteristics in patients with vascular complications of type 1 diabetes mellitus and different pathways of compensation Klinicheskaia Meditsina 91(2): 14-18
Iakovlev, G.M.; Kholmogorov, V.E.; Kozhemiakin, L.A.; Drygin, A.N.; Krylenkov, V.A. 1989: Use of autoblood photomodification in combined therapy of patients with diabetes mellitus of the non-insulin-dependent type Problemy Endokrinologii 35(2): 22-27
Zargar, A.H.; Masoodi, S.R.; Laway, B.A.; Wani, A.I.; Bashir, M.I. 2002: Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure Journal of the Association of Physicians of India 50(5): 641-646
Kozek, E.; Górska, A.; Fross, K.; Marcinowska, A.; Citkowska, A.; Sieradzki, J. 2003: Chronic complications and risk factors in patients with type 1 diabetes mellitus--retrospective analysis Przeglad Lekarski 60(12): 773-777
Andreas Pfützner; Weber, M.M.; Forst, T. 2008: A Biomarker Concept for Assessment of Insulin Resistance, ß-Cell Function and Chronic Systemic Inflammation in Type 2 Diabetes Mellitus Clinical Laboratory 54(11-12): 485-490
Hayward, R.A.; Manning, W.G.; Kaplan, S.H.; Wagner, E.H.; Greenfield, S. 1997: Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization JAMA 278(20): 1663-1669
Bogdanski, P.; Pupek-Musialik, D.; Dytfeld, J.; Jagodzinski, P.P.; Jablecka, A.; Kujawa, A.; Musialik, K. 2007: Influence of insulin therapy on expression of chemokine receptor CCR5 and selected inflammatory markers in patients with type 2 diabetes mellitus International Journal of Clinical Pharmacology and Therapeutics 45(10): 563-567
Steffes, M.W. 1997: Glycemic control and the initiation and progression of the complications of diabetes mellitus Kidney International. Suppl 63: S36-S39
Sokolov, E.I.; Baluda, M.V.; Novikova, I.V.; Balabolkin, M.I.; Beloshitskaia, N.I. 1989: Antithrombogenic activity of the vascular wall in patients with diabetes mellitus and its role in the development of vascular complications Kardiologiia 29(6): 112-114
Gorus, F.K. 1996: The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 58(5): 539-586